Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents

SAN DIEGO and DUBLIN, Dec. 8, 2022 /PRNewswire/ — Crown Bioscience, Inc and ERS Genomics Limited (‘ERS’) have signed a global license agreement for access to the foundational CRISPR/Cas9 patent portfolio held by ERS, which provides the company full license to operate globally using…

Published on : 2022-12-08 08:00:00

Source :cision

Article from : See Article

See also  RBI extends dispensation on HTM bond books till March 2024